VYLOY
Google image searchProduct monograph
Active ingredient
zolbetuximab, 100 MG/VIAL
DIN: 02553996
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE USE VIAL
Schedule: Schedule D / Prescription
Company: ASTELLAS PHARMA CANADA INC
Date: 01-APR-2025
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
- L01FX — Other monoclonal antibodies and antibody drug conjugates (ATC, ATC/DDD)
- L01FX31 — ZOLBETUXIMAB (ATC/DDD)
